Aradigm Corp.

Aradigm Corporation, a pharmaceutical company, engages in the development and commercialization of drugs delivered by inhalation for the treatment of respiratory diseases by pulmonologists in the United States. The company’s activities include development programs addressing the treatment of cystic fibrosis, bronchiectasis, pulmonary arterial hypertension, chronic obstructive pulmonary disease, inhalation anthrax infections, and smoking cessation.

Ticker:
ARDM
Exchange:
OTC (See More OTC Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?